Cancer
Malignant Thyroid Gland Neoplasm
CI-CAN-00003251Explore in graph →
Top-level176 active trials10 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00003251Explore in graph →
Clinical trials
790 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (65)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06037174 | Comparison of Quality of Life in Patients with Differentiated Thyroid Carcinoma Undergoing Different Surgery | unknown | — | 230 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Oct 3, 2024 | clinicaltrials |
| NCT06530771 | Multimodality US Based on Angio Planewave Ultrasensitive Imaging and Shear Wave Elastography to Evaluate the Malignancy Risk Value of Thyroid Nodules | unknown | — | 720 | Fifth Affiliated Hospital, Sun Yat-Sen UniversityOTHER |
| 1 |
| Jul 31, 2024 |
| clinicaltrials |
| NCT06520319 | Head-to-head Study of 68Ga-MGS5 Versus 68Ga-DOTATATE PET/CT in Patients With Medullary Thyroid Carcinoma | unknown | Phase 1 | 20 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | Jul 25, 2024 | clinicaltrials |
| NCT06468696 | Improvements in Thyroid Tumor Surgery and the Prognosis, Diagnosis, Recurrence and Metastasis of Patients | unknown | N/A | 170 | Second Affiliated Hospital of Xi'an Jiaotong UniversityOTHER | 1 | Jun 21, 2024 | clinicaltrials |
| NCT05412680 | Transoral Endoscopic Thyroidectomy by Vestibular Approach (TOETVA)(TOETVA) | unknown | N/A | 60 | Fábio de Aquino CapelliOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT05747365 | Role of Endocrine Disruptors in Thyroid Cancer(THY-ED) | unknown | — | 222 | Istituto Auxologico ItalianoOTHER | 1 | Apr 16, 2024 | clinicaltrials |
| NCT06363123 | Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis | unknown | — | 2,700 | Beijing Friendship HospitalOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT06362694 | Study of the Rechallenge Concept in Patients With BRAF-positive Anaplastic Thyroid Cancer After Progression on Anti-BRAF Therapy | unknown | Phase 2 | 10 | Saint Petersburg State University, RussiaOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT04354324 | Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma | unknown | N/A | 254 | Zhujiang HospitalOTHER | 1 | Mar 15, 2024 | clinicaltrials |
| NCT06269731 | Anxiety & Depression in Thyroid Cancer Patients | unknown | — | 159 | Assiut UniversityOTHER | 0 | Feb 21, 2024 | clinicaltrials |
| NCT05675605 | A Study of TY-1091 in Patients With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 248 | TYK Medicines, IncINDUSTRY | 1 | Jan 30, 2024 | clinicaltrials |
| NCT06101043 | PECS II Block and Single Port Robot-assisted Transaxillary Thyroidectomy | unknown | N/A | 76 | Min Suk ChaeOTHER | 0 | Jan 5, 2024 | clinicaltrials |
| NCT05949424 | OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults(OPTI-DOSE) | unknown | Phase 4 | 30 | University Medical Center GroningenOTHER | 1 | Nov 29, 2023 | clinicaltrials |
| NCT06146985 | Famitinib in Combination With Adebrelimab for the Treatment of Advanced Thyroid Cancer | unknown | Phase 2 | 67 | Ruijin HospitalOTHER | 0 | Nov 28, 2023 | clinicaltrials |
| NCT05989555 | Effects of Radioactive Iodine on the Immune System in Thyroid Cancer(SCIMITAR) | unknown | — | 30 | Radboud University Medical CenterOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT05182931 | A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study)(I-FIRST) | unknown | Phase 2 | 80 | Olivia Newton-John Cancer Research InstituteOTHER | 1 | Oct 31, 2023 | clinicaltrials |
| NCT05545852 | A Clinical Study of Transaxillary Endoscopic and Open Thyroidectomy for PTC | unknown | N/A | 290 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Oct 18, 2023 | clinicaltrials |
| NCT06051747 | Patient-Customized Bioprinting Technology for Practical Regeneration of the Respiratory Tract (Trachea) | unknown | Phase 1 / Phase 2 | 1 | Ja Seong Bae, MD, phDOTHER | 1 | Sep 25, 2023 | clinicaltrials |
| NCT05102292 | The Efficacy and Safety of HLX208 in Advanced Anaplastic Thyroid Cancer (ATC) With BRAF V600 Mutation | unknown | Phase 1 / Phase 2 | 25 | Shanghai Henlius BiotechINDUSTRY | 1 | Aug 21, 2023 | clinicaltrials |
| NCT02814032 | Proteomics of Papillary Thyroid Carcinoma | unknown | — | 32 | The Affiliated Hospital of Inner Mongolia Medical UniversityOTHER | 1 | Jul 20, 2023 | clinicaltrials |
| NCT05932121 | Cross-sectional Case and Control Study on Quality of Life, Appearance and Functions in PTC Via Different Surgical Approach | unknown | — | 300 | Peking Union Medical College HospitalOTHER | 1 | Jul 6, 2023 | clinicaltrials |
| NCT04619316 | Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancers With MAPK Inhibition(ERRITI) | unknown | Phase 2 | 70 | University Hospital, EssenOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT05824312 | HRQOL in Locally Advanced Thyroid Carcinoma(LATCQOL) | unknown | — | 80 | Fujian Cancer HospitalOTHER_GOV | 1 | Apr 21, 2023 | clinicaltrials |
| NCT05819593 | Evaluating Trends in Anaplastic Thyroid Cancer Patients' Clinical Study Experiences | unknown | — | 500 | Power Life Sciences Inc.INDUSTRY | 0 | Apr 19, 2023 | clinicaltrials |
| NCT05278364 | Phase I/II Study of SY-5007, a RET Inhibitor, in Patients With RET-altered Advanced Solid Tumor | unknown | Phase 1 / Phase 2 | 184 | Shouyao Holdings (Beijing) Co. LTDOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT05796960 | European Multicenter Study on Surgical Management of Advanced Thyroid Cancer(ATCEU) | unknown | — | 3,917 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 4, 2023 | clinicaltrials |
| NCT03905369 | Focus on Values to Stimulate Shared Decisions | unknown | N/A | 128 | Radboud University Medical CenterOTHER | 1 | Apr 3, 2023 | clinicaltrials |
| NCT05758025 | A New Surgical Strategy to Protect the Inferior Parathyroid | unknown | N/A | 506 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Mar 7, 2023 | clinicaltrials |
| NCT03475953 | A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors(REGOMUNE) | unknown | Phase 1 / Phase 2 | 747 | Institut BergoniéOTHER | 1 | Mar 3, 2023 | clinicaltrials |
| NCT05395429 | Clinical Evaluation of Genetron TERT/BRAF PCR Kit in Thyroid Cancer Patients | unknown | — | 1,000 | Genetron HealthINDUSTRY | 1 | Feb 23, 2023 | clinicaltrials |
| NCT05659186 | PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer | unknown | Phase 2 | 20 | West China HospitalOTHER | 1 | Dec 21, 2022 | clinicaltrials |
| NCT03432299 | Radiofrequency Ablation of Low Risk Papillary Thyroid Microcarcinoma(RFAforPTMC) | unknown | N/A | 100 | Seoul National University HospitalOTHER | 1 | Oct 26, 2022 | clinicaltrials |
| NCT05468554 | Evaluation of Metformin Effect on the Fertility of Women Treated With 131I for Thyroid Cancer(METHYR) | unknown | Phase 3 | 160 | Medical University of BialystokOTHER | 1 | Oct 19, 2022 | clinicaltrials |
| NCT05510609 | Three-dimensional Ultrasonography Thyroid Volume Measurement. | unknown | N/A | 17 | Rigshospitalet, DenmarkOTHER | 1 | Aug 22, 2022 | clinicaltrials |
| NCT03830242 | Diagnostic Significance of FDG PET/CT Dynamic Imaging in Detecting Metastatic Lymph Nodes With Papillary Thyroid Cancer. | unknown | N/A | 50 | Fifth Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Jul 28, 2022 | clinicaltrials |
| NCT05446441 | Endoscopic Thyroidectomy Versus Open Thyroidectomy for Papillary Thyroid Carcinoma | unknown | N/A | 634 | Zhejiang Provincial People's HospitalOTHER | 0 | Jul 6, 2022 | clinicaltrials |
| NCT04931576 | No Drainage During Transoral Endoscopic Thyroidectomy Vestibular Approach(TOETVA) | unknown | N/A | 600 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jun 23, 2022 | clinicaltrials |
| NCT03657654 | Voice Outcomes Following Thyroidectomy | unknown | — | 45 | University of VirginiaOTHER | 1 | May 9, 2022 | clinicaltrials |
| NCT04842994 | Trial on Intraoperative Neuromonitoring (IONM) in Thyroid Cancer Surgery.(ACTION) | unknown | N/A | 448 | Tata Memorial HospitalOTHER_GOV | 1 | May 5, 2022 | clinicaltrials |
| NCT03669432 | To Study the Impact of Radiation Treatment After Surgery in Patient With Locally Advanced Thyroid Cancer.(THYRO-RT) | unknown | N/A | 72 | Tata Memorial HospitalOTHER_GOV | 1 | May 2, 2022 | clinicaltrials |
| NCT05323669 | Molecular Profile of Thyroid Nodules(MPTN) | unknown | — | 400 | Belarusian State Medical UniversityOTHER | 0 | Apr 12, 2022 | clinicaltrials |
| NCT05218395 | Association Between Persistent Organic Pollutants and Type 2 Diabetes /Thyroid Cancer | unknown | — | 900 | Qianfoshan HospitalOTHER | 1 | Feb 24, 2022 | clinicaltrials |
| NCT04787328 | A Study of HA121-28 Tablets in Patients With Medullary Thyroid Carcinoma (MTC) | unknown | Phase 2 | 30 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Feb 23, 2022 | clinicaltrials |
| NCT04320901 | Energy Device Study in Transoral Endoscopic Thyroidectomy | unknown | N/A | 40 | Inha University HospitalOTHER | 1 | Feb 21, 2022 | clinicaltrials |
| NCT05247476 | Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients. | unknown | Phase 4 | 50 | Zhongshan Hospital Xiamen UniversityOTHER | 1 | Feb 18, 2022 | clinicaltrials |
| NCT04952493 | Anlotinib or Penpulimab in Combination With RAI for DTC | unknown | Phase 2 | 42 | Peking Union Medical College HospitalOTHER | 1 | Jan 28, 2022 | clinicaltrials |
| NCT05124938 | Assessment of CA 19-9 in Patients' With Thyroid Malignancies | unknown | — | 120 | Sohag UniversityOTHER | 1 | Nov 18, 2021 | clinicaltrials |
| NCT02041260 | A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting | unknown | Phase 2 | 43 | Thomas Jefferson UniversityOTHER | 1 | Oct 15, 2021 | clinicaltrials |
| NCT03942380 | Cell-free Tumor DNA in Head and Neck Cancer Patients | unknown | N/A | 500 | Christian von BuchwaldOTHER | 1 | Sep 21, 2021 | clinicaltrials |
| NCT04853680 | Effect of Anti-adhesion Barrier on the Voice Quality After Thyroidectomy. | unknown | N/A | 80 | Inha University HospitalOTHER | 1 | Aug 25, 2021 | clinicaltrials |
Data updated 22 days agoSource updated Oct 3, 2024source: clinicaltrials